SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-023733
Filing Date
2019-09-17
Accepted
2019-09-17 16:05:20
Documents
1
Period of Report
2019-09-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 24118
  Complete submission text file 0000899243-19-023733.txt   25548
Mailing Address C/O CIVITAS THERAPEUTICS, INC. 190 EVERETT AVENUE CHELSEA MA 02150
Business Address
Shah Rajeev M. (Reporting) CIK: 0001619841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39041 | Film No.: 191097198

Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Issuer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations